Ambeed.cn

首页 / / / IDH / BAY-1436032

BAY-1436032 {[allProObj[0].p_purity_real_show]}

货号:A169849 Ambeed 开学季,买赠积分,赢豪礼

BAY 1436032 is a potent, selective and orally available inhibitor of mutant Isocitrate Dehydrogenase 1 (mIDH1).

BAY-1436032 化学结构 CAS号:1803274-65-8
BAY-1436032 化学结构
CAS号:1803274-65-8
BAY-1436032 3D分子结构
CAS号:1803274-65-8
BAY-1436032 化学结构 CAS号:1803274-65-8
BAY-1436032 3D分子结构 CAS号:1803274-65-8
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

BAY-1436032 纯度/质量文件 产品仅供科研

货号:A169849 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JACS Au, 2024. Ambeed. [ A148168 ]
JMC, 2024. Ambeed. [ A187643 ]
JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]
Biomacromolecules, 2024. Ambeed. [ A110759 ]
Biomacromolecules, 2024. Ambeed. [ A203543 ]
更多 >

BAY-1436032 生物活性

描述 BAY-1436032, identified as a comprehensive mutant IDH1 inhibitor, curtails the production of intracellular (R)-2-hydroxyglutarate (R-2HG) in mouse hematopoietic cells harboring IDH1R132H or IDH1R132C mutations, with IC50s of 60 and 45 nM, respectively. It does not affect R-2HG levels in cells expressing IDH2R140Q and IDH2R172K up to a concentration of 10 μM. A 0.1 μM concentration of BAY-1436032 inhibits colony growth by 50%, while up to 100 μM does not hinder the colony growth of AML cells with wild-type IDH1. BAY-1436032 notably induces myelomonocytic differentiation in myeloid progenitors[1].

BAY-1436032 动物研究

Animal study Chronic oral administration of BAY-1436032 results in almost complete inhibition of (R)-2-hydroxyglutarate (R-2HG) production at a dose of 150 mg/kg. White blood cell counts rise continuously in control mice and to a lesser extent in those treated with 45 mg/kg BAY-1436032, but remain stable in the 150 mg/kg group. Hemoglobin levels are marginally lower in the control and 45 mg/kg groups compared to the 150 mg/kg group at day 60, while platelet counts are significantly lower in the control and 45 mg/kg groups than in the 150 mg/kg group at the same time point. All mice treated with 150 mg/kg BAY-1436032 survive with minimal hCD45+ cells in their blood until day 150 post-treatment, whereas control mice succumb to leukemia with a median survival of 91 days. Mice receiving 45 mg/kg BAY-1436032 show intermediate CD14/CD15 expression levels[1].

BAY-1436032 参考文献

[1]Chaturvedi A, et al. Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo. Leukemia. 2017 Oct;31(10):2020-2028.

BAY-1436032 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.04mL

0.41mL

0.20mL

10.21mL

2.04mL

1.02mL

20.43mL

4.09mL

2.04mL

BAY-1436032 技术信息

CAS号1803274-65-8
分子式C26H30F3N3O3
分子量 489.53
别名
运输蓝冰
存储条件

粉末 Keep in dark place,Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 120 mg/mL(245.13 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。